e-learning
resources
Barcelona 2013
Monday, 09.09.2013
Hot topics on airway diseases: new horizons in treatment
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
LATE-BREAKING ABSTRACT: The critical role of interferon-gamma signaling in the respiratory immune response to influenza infection
D. M Kemeny, N. Prabhu, A. W Ho, K. H Wong, B. C. Chua, P. E Hutchinson, B. Sivasankar (Sinagpore, Singapore, Singapore)
Source:
Annual Congress 2013 –Hot topics on airway diseases: new horizons in treatment
Session:
Hot topics on airway diseases: new horizons in treatment
Session type:
Oral Presentation
Number:
1967
Disease area:
Airway diseases, Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
D. M Kemeny, N. Prabhu, A. W Ho, K. H Wong, B. C. Chua, P. E Hutchinson, B. Sivasankar (Sinagpore, Singapore, Singapore). LATE-BREAKING ABSTRACT: The critical role of interferon-gamma signaling in the respiratory immune response to influenza infection. Eur Respir J 2013; 42: Suppl. 57, 1967
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Emerging classes of drugs for the treatment of obstructive lung disease
Definition and history of sarcoidosis
Related content which might interest you:
LATE-BREAKING ABSTRACT: The role of IL-17A in the pathogenesis of early infection with RSV increasing susceptibility to asthma
Source: International Congress 2015 – Emerging strategies for airway disease treatments
Year: 2015
LATE-BREAKING ABSTRACT: IL-5-induced airways eosinophilia as a negative regulator of TLR7 expression may impair the interferon response to rhinovirus in allergic airways
Source: International Congress 2014 – The future has started: emerging potentials for personalised asthma treatment
Year: 2014
LATE-BREAKING ABSTRACT: Airway recruitment and anti-viral function of dendritic cells in asthmatic patients during RV-16 infection
Source: International Congress 2016 – Emerging concepts in lung disease pathogenesis
Year: 2016
LATE-BREAKING ABSTRACT: IL33 drives humoral and cellular immune response in influenza-induced severe exacerbation of experimental asthma
Source: International Congress 2016 – Clinical and molecular studies in asthma
Year: 2016
Mapping the cellular source and role of IL-22 in murine lung infections
Source: International Congress 2015 – Viral infections: basic research and clinical perspective
Year: 2015
LATE-BREAKING ABSTRACT: Interleukin-33 augments rhinovirus-induced type 2 immune responses in people with asthma, but not in healthy donors
Source: International Congress 2015 – Emerging strategies for airway disease treatments
Year: 2015
LATE-BREAKING ABSTRACT: Inhibition of Pim1 kinase augments the anti-viral response to rhinovirus infection.
Source: International Congress 2014 – COPD exacerbations
Year: 2014
LATE-BREAKING ABSTRACT: Oxidation of the alarmin IL-33 regulates ST2-dependent inflammation
Source: International Congress 2015 – Hot topics on airway diseases: new horizons in treatment
Year: 2015
LATE-BREAKING ABSTRACT: Effect of calcineurin inhibitors on the host innate immune response to invasive aspergillosis in alveolar macrophages.
Source: International Congress 2014 – Chronic lung allograft dysfunction: mechanisms, predictors and phenotypes
Year: 2014
LATE-BREAKING ABSTRACT: TSLP as a potent activator of Th2 response in obstructive lung diseases
Source: International Congress 2016 – Novel mechanisms and therapeutic targets in acute and chronic inflammatory disease
Year: 2016
Innate immunity but not NLRP3 inflammasome activation correlates with severity of stable COPD
Source: Annual Congress 2013 –Predictors and triggers of asthma and COPD exacerbations
Year: 2013
RSV infection modulates IL-15 production and MICA levels in respiratory epithelial cells
Source: Eur Respir J 2012; 39: 712-720
Year: 2012
Activation of NLRP3 inflammasome is regulated by mitochondrial ROS via PI3K-HIF-VEGF pathway in acute lung injury
Source: International Congress 2015 – Novel insights into the pathobiology of acute lung injury
Year: 2015
Investigation of the innate antiviral response to respiratory syncytial virus
Source: International Congress 2015 – Paediatric pulmonary infections: mechanisms and treatment
Year: 2015
Role of the immunoregulatory microRNA miR-146a in the innate immune response to rhinovirus infection
Source: Annual Congress 2013 –Viral infections: what is new?
Year: 2013
Modulation of PD-1 and PD-L1 expression in response to acute viral infection of human lung tissue
Source: International Congress 2014 – Cell biology 2014
Year: 2014
The monocyte-dependent immune response to bacterial infections is systemically suppressed in COPD
Source: International Congress 2014 – Allergy and asthma: novel findings based on human cell biology
Year: 2014
Human rhinovirus impairs macrophage innate immune responses to bacteria via the interferon pathway in COPD
Source: International Congress 2018 – The airway microbiome across the spectrum of airway disease
Year: 2018
Crosstalk between lung fibroblasts and T-lymphocytes: Implications for anti-viral responses in chronic lung disease
Source: Annual Congress 2013 –Asthma: new mechanisms and markers
Year: 2013
Upregulation of CCL5 production in the airway epithelium at the time of the viral infection
Source: International Congress 2016 – Airway response to infection
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept